Compare Stocks: BVS, LIVN, ITGR, and PLSE

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$12.98 -0.6%	$13.24	$6.26 ▼ $15.89	$1.09B	0.65	531,747 shs	421,805 shs
ITGR Integer	$126.07 +0.0%	$114.21	$62.00 ▼ $126.79	$4.28B	0.62	705,922 shs	449,895 shs
LIVN LivaNova	$78.18	$80.35	$48.82 ▼ $85.76	$4.31B	0.87	535,972 shs	552,414 shs
PLSE Pulse Biosciences	$53.11 -2.4%	$40.35	$12.56 ▼ $58.90	$3.68B	1.63	581,439 shs	664,302 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	0.00%	-7.75%	-6.55%	+52.53%	+85.43%
ITGR Integer	0.00%	-0.27%	+0.80%	+38.58%	+23.07%
LIVN LivaNova	0.00%	-4.57%	-4.89%	-1.52%	+38.32%
PLSE Pulse Biosciences	0.00%	-0.24%	+18.23%	+117.93%	+259.58%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$12.98 -0.6%	$13.24	$6.26 ▼ $15.89	$1.09B	0.65	531,747 shs	421,805 shs
ITGR Integer	$126.07 +0.0%	$114.21	$62.00 ▼ $126.79	$4.28B	0.62	705,922 shs	449,895 shs
LIVN LivaNova	$78.18	$80.35	$48.82 ▼ $85.76	$4.31B	0.87	535,972 shs	552,414 shs
PLSE Pulse Biosciences	$53.11 -2.4%	$40.35	$12.56 ▼ $58.90	$3.68B	1.63	581,439 shs	664,302 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	0.00%	-7.75%	-6.55%	+52.53%	+85.43%
ITGR Integer	0.00%	-0.27%	+0.80%	+38.58%	+23.07%
LIVN LivaNova	0.00%	-4.57%	-4.89%	-1.52%	+38.32%
PLSE Pulse Biosciences	0.00%	-0.24%	+18.23%	+117.93%	+259.58%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BVS Bioventus	2.83	Moderate Buy	$16.80	29.43% Upside
ITGR Integer	2.07	Hold	$109.86	-12.86% Downside
LIVN LivaNova	2.55	Moderate Buy	$84.13	7.60% Upside
PLSE Pulse Biosciences	2.83	Moderate Buy	$45.25	-14.80% Downside

Current Analyst Ratings Breakdown

Latest BVS, LIVN, ITGR, and PLSE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	PLSE Pulse Biosciences	Freedom Capmkts Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
9/2/2026	LIVN LivaNova	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$87.00 ➝ $90.00
8/19/2026	LIVN LivaNova	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/18/2026	LIVN LivaNova	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/17/2026	BVS Bioventus	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $19.00
8/17/2026	BVS Bioventus	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$15.00
8/17/2026	PLSE Pulse Biosciences	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$58.00
8/13/2026	ITGR Integer	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/10/2026	PLSE Pulse Biosciences	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$45.00
8/10/2026	PLSE Pulse Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $43.00
8/6/2026	BVS Bioventus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)

(Data available from 9/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BVS Bioventus	$568.09M	1.92	$1.28 per share	10.18	$2.76 per share	4.70
ITGR Integer	$1.85B	2.31	$10.38 per share	12.15	$49.85 per share	2.53
LIVN LivaNova	$1.39B	3.10	$4.83 per share	16.17	$21.98 per share	3.56
PLSE Pulse Biosciences	$350K	10,502.12	N/A	N/A	$1.19 per share	44.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BVS Bioventus	$22.73M	$0.77	16.86	14.58	1.65	9.36%	28.08%	9.82%	N/A
ITGR Integer	$102.81M	$3.66	34.44	18.79	2.40	6.97%	12.79%	6.48%	10/22/2026 (Estimated)
LIVN LivaNova	-$242.47M	$3.38	23.13	18.88	N/A	12.82%	16.35%	7.76%	11/4/2026 (Estimated)
PLSE Pulse Biosciences	-$72.78M	-$1.18	N/A	N/A	N/A	-6,755.78%	-94.42%	-79.96%	11/4/2026 (Estimated)

Latest BVS, LIVN, ITGR, and PLSE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	LIVN LivaNova	$1.09	$1.26	+$0.17	$1.93	$380.50 million	$390.59 million
8/6/2026	Q2 2026	PLSE Pulse Biosciences	-$0.2933	-$0.36	-$0.0667	-$0.36	$0.53 million	$0.43 million
8/5/2026	Q2 2026	BVS Bioventus	$0.22	$0.22	N/A	$0.47	N/A	$153.21 million
8/3/2026	Q2 2026	ITGR Integer	$1.38	$1.60	+$0.22	$0.69	$451.07 million	$464.11 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
ITGR Integer	N/A	N/A	N/A	N/A	N/A
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BVS Bioventus	0.83	1.69	1.17
ITGR Integer	0.75	3.73	2.41
LIVN LivaNova	0.22	1.45	1.21
PLSE Pulse Biosciences	N/A	9.63	9.61

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BVS Bioventus	62.94%
ITGR Integer	99.29%
LIVN LivaNova	97.64%
PLSE Pulse Biosciences	76.95%

Insider Ownership

Company	Insider Ownership
BVS Bioventus	33.50%
ITGR Integer	1.10%
LIVN LivaNova	0.35%
PLSE Pulse Biosciences	74.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BVS Bioventus	950	84.09 million	55.92 million	N/A
ITGR Integer	11,000	33.99 million	33.62 million	Optionable
LIVN LivaNova	3,300	55.09 million	54.90 million	Optionable
PLSE Pulse Biosciences	116	69.21 million	18.00 million	Optionable

BVS, LIVN, ITGR, and PLSE Headlines

Recent News About These Companies

Pulse Biosciences (NASDAQ:PLSE) Sets New 12-Month High Following Analyst Upgrade

September 12 at 3:41 AM | americanbankingnews.com

Pulse Biosciences (NASDAQ:PLSE) Upgraded by Freedom Capmkts to Strong-Buy Rating

September 11 at 6:35 AM | marketbeat.com

Pulse Biosciences, Inc (NASDAQ:PLSE) Receives Consensus Rating of "Moderate Buy" from Brokerages

September 11 at 6:13 AM | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Reaches New 12-Month High - Should You Buy?

September 10 at 4:39 AM | marketbeat.com

Bank of New York Mellon Corp Invests $1.20 Million in Pulse Biosciences, Inc $PLSE

September 10 at 3:36 AM | marketbeat.com

Freedom Capital Markets initiates coverage of Pulse Biosciences with a buy rating

September 9, 2026 | msn.com

Why Pulse Biosciences Stock Popped Today

September 9, 2026 | fool.com

Pulse Biosciences (NASDAQ:PLSE) Trading Up 5.3% - Here's Why

September 9, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Shares Down 7.3% - Here's What Happened

September 8, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Upgraded at Wall Street Zen

September 6, 2026 | americanbankingnews.com

Pulse Biosciences (NASDAQ:PLSE) Upgraded to Hold at Wall Street Zen

September 6, 2026 | marketbeat.com

Insider Buying: Pulse Biosciences (NASDAQ:PLSE) COO Acquires $49,971.20 in Stock

September 3, 2026 | insidertrades.com

Pulse Biosciences (NASDAQ:PLSE) COO Liane Rae Teplitsky Buys 1,024 Shares

September 2, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) COO Liane Rae Teplitsky Buys 1,001 Shares of Stock

September 2, 2026 | marketbeat.com

BlackRock Inc. Takes $40.67 Million Position in Pulse Biosciences, Inc $PLSE

September 2, 2026 | marketbeat.com

Deutsche Bank AG Takes Position in Pulse Biosciences, Inc $PLSE

September 2, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month High - Still a Buy?

September 1, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.1% Following Insider Buying Activity

August 31, 2026 | marketbeat.com

Liane Rae Teplitsky Purchases 1,036 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock

August 29, 2026 | insidertrades.com

Pulse Biosciences (NASDAQ:PLSE) Upgraded by Wall Street Zen to "Hold" Rating

August 29, 2026 | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) COO Liane Rae Teplitsky Buys 1,036 Shares

August 28, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BVS, LIVN, ITGR, and PLSE Company Descriptions

Bioventus NASDAQ:BVS

$12.98 -0.08 (-0.61%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$12.88 -0.10 (-0.73%)

As of 09/11/2026 07:30 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Integer NYSE:ITGR

$126.06 +0.02 (+0.01%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$125.96 -0.10 (-0.08%)

As of 09/11/2026 07:30 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova NASDAQ:LIVN

$78.18 0.00 (0.00%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$78.18 0.00 (0.00%)

As of 09/11/2026 07:30 PM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Pulse Biosciences NASDAQ:PLSE

$53.11 -1.32 (-2.43%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$54.02 +0.91 (+1.72%)

As of 09/11/2026 07:30 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BVS, LIVN, ITGR, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BVS, LIVN, ITGR, and PLSE Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BVS, LIVN, ITGR, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BVS, LIVN, ITGR, and PLSE Company Descriptions

Bioventus NASDAQ:BVS

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BVS, LIVN, ITGR, and PLSE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BVS, LIVN, ITGR, and PLSE Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BVS, LIVN, ITGR, and PLSE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BVS, LIVN, ITGR, and PLSE Company Descriptions

Bioventus NASDAQ:BVS

Integer NYSE:ITGR

LivaNova NASDAQ:LIVN

Pulse Biosciences NASDAQ:PLSE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools